Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06294431 · ClinicalTrials.gov registry record · NA
Radicle Clarity 24: A Study of Health and Wellness Products on Cognitive Function and Related Health Outcomes
A NA study, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 4,794
- Enrollment target
NCT06294431: Completed NA study, sponsored by Radicle Science.
NCT06294431 is a NA study that has completed, run by Radicle Science. The registered enrollment target is 4,794 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (241% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06294431, a NA study, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,794 participants
- Enrollment target
Study Summary
A randomized, double-blind, placebo-controlled direct-to-consumer study of health and wellness products on cognitive function and related health outcomes
Primary Outcome
Mean difference in cognition function score as assessed by Patient Reported Outcome Measurement System (PROMIS) Cognitive Function Short Form 8A (scale 8-40; where the higher scores correspond to greater cognitive function)
Interventions
- DIETARY_SUPPLEMENT Clarity Active Study Product 1.1 Usage
- DIETARY_SUPPLEMENT Clarity Active Study Product 2.1 Usage
- DIETARY_SUPPLEMENT Placebo Control Form 1
- DIETARY_SUPPLEMENT Placebo Control Form 2
- DIETARY_SUPPLEMENT Placebo Control Form 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,794 participants |
| Start Date | 2024-03-04 |
| Est. Completion | 2025-08-15 |
| Phase | NA |
What the finished NCT06294431 record still lists
NCT06294431 is an interventional study that assigns participants to a tested intervention. Its 4,794 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (241% higher).
The record links to 0 conditions, and to 5 interventions - of which Clarity Active Study Product 1.1 Usage is the first listed.
NCT06294431 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06294431 about?
NCT06294431 is a clinical study titled "Radicle Clarity 24: A Study of Health and Wellness Products on Cognitive Function and Related Health Outcomes". A randomized, double-blind, placebo-controlled direct-to-consumer study of health and wellness products on cognitive function and related health outcomes
What is the current status of trial NCT06294431?
This trial is currently completed. It is a NA study. The enrollment target is 4,794 participants. The study started on 2024-03-04. Estimated completion is 2025-08-15.
What interventions are being tested in trial NCT06294431?
The interventions under investigation include: Clarity Active Study Product 1.1 Usage (DIETARY_SUPPLEMENT), Clarity Active Study Product 2.1 Usage (DIETARY_SUPPLEMENT), Placebo Control Form 1 (DIETARY_SUPPLEMENT), Placebo Control Form 2 (DIETARY_SUPPLEMENT), Placebo Control Form 3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06294431?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06294431's enrollment target sits among peer trials
4,794 28th of 2000 higher than 1,973 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01719055 · 4,800 participants
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- NCT05485675 · 4,800 participants · NA
Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program
- NCT06307652 · 4,800 participants · Phase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- NCT05252754 · 4,874 participants · Phase 3
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI